4//SEC Filing
Beddingfield III Frederick 4
Accession 0001562180-19-003848
CIK 0001656328other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:35 PM ET
Size
6.7 KB
Accession
0001562180-19-003848
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2019-07-02$0.76/sh−17,063$12,968→ 817,599 total
Holdings
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares otherwise issuable to the Reporting Person that were withheld to satisfy the Issuer's tax withholding obligation upon settlement of restricted stock units.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.72 to $0.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes a total of 5,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F4]The shares are directly held by the Beddingfield Family Trust.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001573074
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 1:35 PM ET
- Size
- 6.7 KB